Get Started

IMGN

ImmunoGen (IMGN)

ImmunoGen Inc

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:IMGN

<< Previous 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 Next >>

Date	Time	Source	Headline	Symbol	Company
05/02/2022	4:30PM	Business Wire	ImmunoGen Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:IMGN	ImmunoGen Inc
04/21/2022	4:01PM	Business Wire	ImmunoGen Announces Conference Call to Discuss Its First Quarter 2022 Operating Results	NASDAQ:IMGN	ImmunoGen Inc
04/20/2022	5:39PM	Edgar (US Regulatory)	Amended Statement of Changes in Beneficial Ownership (4/a)	NASDAQ:IMGN	ImmunoGen Inc
04/13/2022	5:08PM	Edgar (US Regulatory)	Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)	NASDAQ:IMGN	ImmunoGen Inc
04/04/2022	4:31PM	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:IMGN	ImmunoGen Inc
04/04/2022	4:13PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:IMGN	ImmunoGen Inc
04/04/2022	4:13PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:IMGN	ImmunoGen Inc
04/01/2022	4:30PM	Business Wire	ImmunoGen Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:IMGN	ImmunoGen Inc
03/31/2022	4:30PM	Business Wire	ImmunoGen Announces Webcast of Panel Discussion at Upcoming Canaccord Genuity Horizons in Oncology Virtual Conference	NASDAQ:IMGN	ImmunoGen Inc
03/29/2022	6:30AM	Business Wire	ImmunoGen Submits Biologics License Application to the US Food and Drug Administration for Mirvetuximab Soravtansine in Ovarian Cancer	NASDAQ:IMGN	ImmunoGen Inc
03/28/2022	9:35AM	TipRanks	BMO Capital Thinks ImmunoGen’s Stock is Going to Recover	NASDAQ:IMGN	ImmunoGen Inc
03/22/2022	9:35AM	TipRanks	BMO Capital Thinks ImmunoGen’s Stock is Going to Recover	NASDAQ:IMGN	ImmunoGen Inc
03/22/2022	8:05AM	TipRanks	ImmunoGen (IMGN) Gets a Hold Rating from J.P. Morgan	NASDAQ:IMGN	ImmunoGen Inc
03/21/2022	11:05AM	TipRanks	Analysts’ Opinions Are Mixed on These Healthcare Stocks: ImmunoGen (IMGN) and Decibel Therapeutics (DBTX)	NASDAQ:IMGN	ImmunoGen Inc
03/21/2022	8:46AM	TipRanks	Jefferies Thinks ImmunoGen’s Stock is Going to Recover	NASDAQ:IMGN	ImmunoGen Inc
03/21/2022	6:26AM	TipRanks	H.C. Wainwright Maintains a Buy Rating on ImmunoGen (IMGN)	NASDAQ:IMGN	ImmunoGen Inc
03/19/2022	7:15PM	Business Wire	ImmunoGen Presents Full Results from Positive Pivotal SORAYA Trial of Mirvetuximab Soravtansine in Ovarian Cancer at SGO Annual Meeting	NASDAQ:IMGN	ImmunoGen Inc
03/14/2022	9:45AM	TipRanks	Analysts Offer Insights on Healthcare Companies: Evelo Biosciences (EVLO) and ImmunoGen (IMGN)	NASDAQ:IMGN	ImmunoGen Inc
03/11/2022	2:15PM	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:IMGN	ImmunoGen Inc
03/10/2022	6:30AM	Business Wire	ImmunoGen to Present Full Results from SORAYA Trial of Mirvetuximab Soravtansine in Ovarian Cancer at the Society of Gynecologic Oncology Annual Meeting	NASDAQ:IMGN	ImmunoGen Inc
03/01/2022	4:30PM	Business Wire	ImmunoGen Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:IMGN	ImmunoGen Inc
02/28/2022	5:36PM	Edgar (US Regulatory)	Annual Report (10-k)	NASDAQ:IMGN	ImmunoGen Inc
02/25/2022	7:14AM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:IMGN	ImmunoGen Inc
02/25/2022	6:30AM	Business Wire	ImmunoGen Reports Recent Progress and 2021 Financial Results	NASDAQ:IMGN	ImmunoGen Inc
02/23/2022	4:30PM	Business Wire	ImmunoGen Announces Webcast of Panel Discussion at Upcoming Cowen 42nd Annual Health Care Conference	NASDAQ:IMGN	ImmunoGen Inc
02/15/2022	6:30AM	Business Wire	ImmunoGen Announces a Global, Multi-Target License Agreement of its Novel Camptothecin ADC Platform to Lilly for Up to $1.7 Billion	NASDAQ:IMGN	ImmunoGen Inc
02/14/2022	6:19PM	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:IMGN	ImmunoGen Inc
02/10/2022	4:01PM	Business Wire	ImmunoGen Announces Conference Call to Discuss Its 2021 Operating Results	NASDAQ:IMGN	ImmunoGen Inc
02/10/2022	8:33AM	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:IMGN	ImmunoGen Inc
02/09/2022	9:23AM	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:IMGN	ImmunoGen Inc